{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:18:10Z","timestamp":1786115890651,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["23K18313, 24K02518, 23KK0153, 24K22144, 23K19505, 24K19992, 25H01060"],"award-info":[{"award-number":["23K18313, 24K02518, 23KK0153, 24K22144, 23K19505, 24K19992, 25H01060"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23ym0126809, JP24ym0126809"],"award-info":[{"award-number":["JP23ym0126809, JP24ym0126809"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02880-5","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T06:18:05Z","timestamp":1785997085000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["RNA methyltransferase 3 drives pancreatic acinar cell carcinoma growth and is a therapeutic target"],"prefix":"10.1038","volume":"11","author":[{"given":"Shotaro","family":"Tatekawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sikun","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Tamari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuko","family":"Arao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6960-2315","authenticated-orcid":false,"given":"Masamitsu","family":"Konno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Ofusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Rennie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoharu","family":"Inui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Akita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Motooka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Murakumo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Inohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Doki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideshi","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"2880_CR1","first-page":"1","volume":"62","author":"PC Nowell","year":"1993","unstructured":"Nowell, P. C. Foundations in cancer research. Chromosomes and cancer: the evolution of an idea. Adv. Cancer Res. 62, 1\u201317 (1993).","journal-title":"Adv. Cancer Res."},{"key":"2880_CR2","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41579-020-0382-3","volume":"18","author":"K Tsai","year":"2020","unstructured":"Tsai, K. & Cullen, B. R. Epigenetic and epitranscriptomic regulation of viral replication. Nat. Rev. Microbiol. 18, 559\u2013570 (2020).","journal-title":"Nat. Rev. Microbiol."},{"key":"2880_CR3","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1038\/s12276-025-01537-7","volume":"57","author":"A Verma","year":"2025","unstructured":"Verma, A. & Lindroth, A. M. The emerging intertwined activities of metabolism and epigenetics unveils culprits and prospects in cancer. Exp. Mol. Med. 57, 1928\u20131939 (2025).","journal-title":"Exp. Mol. Med."},{"key":"2880_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. Hallmarks of cancer: new dimensions. Cancer Discov. 12, 31\u201346 (2022).","journal-title":"Cancer Discov."},{"key":"2880_CR5","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1111\/cas.14095","volume":"110","author":"M Konno","year":"2019","unstructured":"Konno, M., Taniguchi, M. & Ishii, H. Significant epitranscriptomes in heterogeneous cancer. Cancer Sci. 110, 2318\u20132327 (2019).","journal-title":"Cancer Sci."},{"key":"2880_CR6","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41568-025-00889-6","volume":"26","author":"H Luo","year":"2026","unstructured":"Luo, H., Kharas, M. G. & Jaffrey, S. R. N(6)-Methyladenosine: an RNA modification as a central regulator of cancer. Nat. Rev. Cancer 26, 118\u2013136 (2026).","journal-title":"Nat. Rev. Cancer"},{"key":"2880_CR7","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.molcel.2016.05.041","volume":"63","author":"P Wang","year":"2016","unstructured":"Wang, P., Doxtader, K. A. & Nam, Y. Structural basis for cooperative function of Mettl3 and Mettl14 Methyltransferases. Mol. Cell 63, 306\u2013317 (2016).","journal-title":"Mol. Cell"},{"key":"2880_CR8","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41422-018-0040-8","volume":"28","author":"Y Yang","year":"2018","unstructured":"Yang, Y., Hsu, P. J., Chen, Y. S. & Yang, Y. G. Dynamic transcriptomic m(6)A decoration: writers, erasers, readers and functions in RNA metabolism. Cell Res. 28, 616\u2013624 (2018).","journal-title":"Cell Res."},{"key":"2880_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1033-z","volume":"18","author":"XY Chen","year":"2019","unstructured":"Chen, X. Y., Zhang, J. & Zhu, J. S. The role of m(6)A RNA methylation in human cancer. Mol. Cancer 18, 103 (2019).","journal-title":"Mol. Cancer"},{"key":"2880_CR10","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.molcel.2016.03.021","volume":"62","author":"S Lin","year":"2016","unstructured":"Lin, S. et al. The m(6)A Methyltransferase METTL3 promotes translation in human cancer cells. Mol. Cell 62, 335\u2013345 (2016).","journal-title":"Mol. Cell"},{"key":"2880_CR11","doi-asserted-by":"publisher","first-page":"7476","DOI":"10.18632\/oncotarget.23554","volume":"9","author":"Y Nishizawa","year":"2018","unstructured":"Nishizawa, Y. et al. Oncogene c-Myc promotes epitranscriptome m(6)A reader YTHDF1 expression in colorectal cancer. Oncotarget 9, 7476\u20137486 (2018).","journal-title":"Oncotarget"},{"key":"2880_CR12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang, X. et al. The role of m6A modification in the biological functions and diseases. Signal Transduct. Target Ther. 6, 74 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"2880_CR13","doi-asserted-by":"crossref","unstructured":"Takeda, Y. et al. Impact of one-carbon metabolism-driving epitranscriptome as a therapeutic target for gastrointestinal cancer. Int. J. Mol. Sci. 22 (2021).","DOI":"10.3390\/ijms22147278"},{"key":"2880_CR14","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.7150\/ijbs.70674","volume":"18","author":"R Yu","year":"2022","unstructured":"Yu, R. et al. Integrative analyses of m6A regulators identify that METTL3 is associated with HPV Status and immunosuppressive microenvironment in HPV-related cancers. Int. J. Biol. Sci. 18, 3874\u20133887 (2022).","journal-title":"Int. J. Biol. Sci."},{"key":"2880_CR15","doi-asserted-by":"publisher","first-page":"507","DOI":"10.7150\/ijbs.67770","volume":"18","author":"C Hu","year":"2022","unstructured":"Hu, C. et al. HPV E6\/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize m(6)A-MYC expression. Int J. Biol. Sci. 18, 507\u2013521 (2022).","journal-title":"Int J. Biol. Sci."},{"key":"2880_CR16","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1016\/j.molcel.2022.04.010","volume":"82","author":"N Raj","year":"2022","unstructured":"Raj, N. et al. The Mettl3 epitranscriptomic writer amplifies p53 stress responses. Mol. Cell 82, 2370\u20132384.e2310 (2022).","journal-title":"Mol. Cell"},{"key":"2880_CR17","first-page":"621","volume":"52","author":"K Taketo","year":"2018","unstructured":"Taketo, K. et al. The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells. Intern J. Oncol. 52, 621\u2013629 (2018).","journal-title":"Intern J. Oncol."},{"key":"2880_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-15196-5","volume":"12","author":"S Tatekawa","year":"2022","unstructured":"Tatekawa, S. et al. N(6)-methyladenosine methylation-regulated polo-like kinase 1 cell cycle homeostasis as a potential target of radiotherapy in pancreatic adenocarcinoma. Sci. Rep. 12, 11074 (2022).","journal-title":"Sci. Rep."},{"key":"2880_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/jjco\/hyad176","volume":"54","author":"K Ikezawa","year":"2024","unstructured":"Ikezawa, K. et al. Comprehensive review of pancreatic acinar cell carcinoma: epidemiology, diagnosis, molecular features and treatment. Jpn J. Clin. Oncol. 54, 271\u2013281 (2024).","journal-title":"Jpn J. Clin. Oncol."},{"key":"2880_CR20","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.pan.2021.05.011","volume":"21","author":"V Sridharan","year":"2021","unstructured":"Sridharan, V. et al. Pancreatic acinar cell carcinoma: A multicenter series on clinical characteristics and treatment outcomes. Pancreatology 21, 1119\u20131126 (2021).","journal-title":"Pancreatology"},{"key":"2880_CR21","doi-asserted-by":"publisher","first-page":"4915","DOI":"10.1158\/1078-0432.CCR-08-2256","volume":"15","author":"N Zhang","year":"2009","unstructured":"Zhang, N., Lyons, S., Lim, E. & Lassota, P. A spontaneous acinar cell carcinoma model for monitoring progression of pancreatic lesions and response to treatment through noninvasive bioluminescence imaging. Clin. Cancer Res. 15, 4915\u20134924 (2009).","journal-title":"Clin. Cancer Res."},{"key":"2880_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.152666","volume":"215","author":"T Xia","year":"2019","unstructured":"Xia, T. et al. The RNA m6A methyltransferase METTL3 promotes pancreatic cancer cell proliferation and invasion. Pathol. Res. Pract. 215, 152666 (2019).","journal-title":"Pathol. Res. Pract."},{"key":"2880_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154702","volume":"116","author":"X Li","year":"2021","unstructured":"Li, X. et al. METTL3 is required for maintaining beta-cell function. Metabolism 116, 154702 (2021).","journal-title":"Metabolism"},{"key":"2880_CR24","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.2337\/db19-0906","volume":"69","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. m(6)A mRNA methylation controls functional maturation in neonatal murine beta-cells. Diabetes 69, 1708\u20131722 (2020).","journal-title":"Diabetes"},{"key":"2880_CR25","first-page":"183","volume":"94","author":"MR Hilleman","year":"1998","unstructured":"Hilleman, M. R. Discovery of simian virus 40 (SV40) and its relationship to poliomyelitis virus vaccines. Dev. Biol. Stand. 94, 183\u2013190 (1998).","journal-title":"Dev. Biol. Stand."},{"key":"2880_CR26","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0092-8674(79)90053-9","volume":"18","author":"AE Smith","year":"1979","unstructured":"Smith, A. E., Smith, R. & Paucha, E. Characterization of different tumor antigens present in cells transformed by simian virus 40. Cell 18, 335\u2013346 (1979).","journal-title":"Cell"},{"key":"2880_CR27","first-page":"1631","volume":"10","author":"S Liu","year":"2020","unstructured":"Liu, S. et al. METTL3 plays multiple functions in biological processes. Am. J. Cancer Res. 10, 1631\u20131646 (2020).","journal-title":"Am. J. Cancer Res"},{"key":"2880_CR28","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41586-018-0538-8","volume":"561","author":"J Choe","year":"2018","unstructured":"Choe, J. et al. mRNA circularization by METTL3-eIF3h enhances translation and promotes oncogenesis. Nature 561, 556\u2013560 (2018).","journal-title":"Nature"},{"key":"2880_CR29","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","volume":"593","author":"E Yankova","year":"2021","unstructured":"Yankova, E. et al. Small-molecule inhibition of METTL3 as a strategy against myeloid leukemia. Nature 593, 597\u2013601 (2021).","journal-title":"Nature"},{"key":"2880_CR30","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/cdd.2009.205","volume":"17","author":"J Hickson","year":"2010","unstructured":"Hickson, J. et al. Noninvasive molecular imaging of apoptosis in vivo using a modified firefly luciferase substrate, Z-DEVD-aminoluciferin. Cell Death Differ. 17, 1003\u20131010 (2010).","journal-title":"Cell Death Differ."},{"key":"2880_CR31","doi-asserted-by":"crossref","unstructured":"Hosein, A. N. et al. Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution. JCI Insight 5, e129212 (2019).","DOI":"10.1101\/539874"},{"key":"2880_CR32","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1136\/gutjnl-2014-307616","volume":"65","author":"B Kong","year":"2016","unstructured":"Kong, B. et al. A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras\/Mek\/Erk-induced hyperactive mTOR signaling. Gut 65, 647\u2013657 (2016).","journal-title":"Gut"},{"key":"2880_CR33","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1053\/j.gastro.2022.09.036","volume":"164","author":"D Fu","year":"2023","unstructured":"Fu, D. et al. Pancreatitis-associated PRSS1-PRSS2 Haplotype alters T-Cell Receptor Beta (TRB) Repertoire more strongly than PRSS1 Expression. Gastroenterology 164, 289\u2013292.e284 (2023).","journal-title":"Gastroenterology"},{"key":"2880_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","volume":"22","author":"TC Chou","year":"1984","unstructured":"Chou, T. C. & Talalay, P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzym. Regul. 22, 27\u201355 (1984).","journal-title":"Adv. Enzym. Regul."},{"key":"2880_CR35","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1248\/bpb.b20-00389","volume":"43","author":"R Morimoto-Kamata","year":"2020","unstructured":"Morimoto-Kamata, R., Tsuji, D. & Yui, S. Cathepsin G-Induced Insulin-Like Growth Factor (IGF) Elevation in MCF-7 Medium Is Caused by Proteolysis of IGF Binding Protein (IGFBP)-2 but Not of IGF-1. Biol. Pharm. Bull. 43, 1678\u20131686 (2020).","journal-title":"Biol. Pharm. Bull."},{"key":"2880_CR36","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/ng1096-141","volume":"14","author":"DC Whitcomb","year":"1996","unstructured":"Whitcomb, D. C. et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat. Genet. 14, 141\u2013145 (1996).","journal-title":"Nat. Genet."},{"key":"2880_CR37","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s00018-025-05653-5","volume":"82","author":"J Zhang","year":"2025","unstructured":"Zhang, J. et al. METTL3-dependent m6A methylation of circCEACAM5 fuels pancreatic cancer progression through DKC1 activation. Cell Mol. Life Sci. 82, 132 (2025).","journal-title":"Cell Mol. Life Sci."},{"key":"2880_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2023.10.004","volume":"97","author":"X Wang","year":"2023","unstructured":"Wang, X., Eichhorn, P. J. A. & Thiery, J. P. TGF-beta, EMT, and resistance to anticancer treatment. Semin. Cancer Biol. 97, 1\u201311 (2023).","journal-title":"Semin. Cancer Biol."},{"key":"2880_CR39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s10020-019-0111-4","volume":"25","author":"Q Liu","year":"2019","unstructured":"Liu, Q. et al. PRSS1 mutation: a possible pathomechanism of pancreatic carcinogenesis and pancreatic cancer. Mol. Med. 25, 44 (2019).","journal-title":"Mol. Med."},{"key":"2880_CR40","doi-asserted-by":"publisher","first-page":"957","DOI":"10.7150\/ijbs.52591","volume":"17","author":"D Ye","year":"2021","unstructured":"Ye, D. et al. Silencing PRSS1 suppresses the growth and proliferation of gastric carcinoma cells via the ERK pathway. Int J. Biol. Sci. 17, 957\u2013971 (2021).","journal-title":"Int J. Biol. Sci."},{"key":"2880_CR41","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1002\/1878-0261.12075","volume":"11","author":"T Kryza","year":"2017","unstructured":"Kryza, T. et al. Kallikrein-related peptidase 4 induces cancer-associated fibroblast features in prostate-derived stromal cells. Mol. Oncol. 11, 1307\u20131329 (2017).","journal-title":"Mol. Oncol."},{"key":"2880_CR42","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1158\/0008-5472.CAN-24-1185","volume":"85","author":"Z Ou","year":"2025","unstructured":"Ou, Z. et al. Hypoxia-induced senescent fibroblasts secrete IGF1 to promote cancer stemness in esophageal squamous cell carcinoma. Cancer Res. 85, 1064\u20131081 (2025).","journal-title":"Cancer Res."},{"key":"2880_CR43","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aax5576","volume":"6","author":"Z Tan","year":"2020","unstructured":"Tan, Z. et al. PRSS contributes to cetuximab resistance in colorectal cancer. Sci. Adv. 6, eaax5576 (2020).","journal-title":"Sci. Adv."},{"key":"2880_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.618341","volume":"8","author":"L Xing","year":"2020","unstructured":"Xing, L. et al. PRSS1 Upregulation predicts platinum resistance in ovarian cancer patients. Front. Cell Dev. Biol. 8, 618341 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"2880_CR45","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/onc.2017.351","volume":"37","author":"A Visvanathan","year":"2018","unstructured":"Visvanathan, A. et al. Essential role of METTL3-mediated m(6)A modification in glioma stem-like cells maintenance and radioresistance. Oncogene 37, 522\u2013533 (2018).","journal-title":"Oncogene"},{"key":"2880_CR46","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1158\/1078-0432.CCR-22-3724","volume":"29","author":"V Florou","year":"2023","unstructured":"Florou, V. et al. Comparative genomic analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC) unveils new actionable genomic aberrations in PACC. Clin. Cancer Res. 29, 3408\u20133417 (2023).","journal-title":"Clin. Cancer Res."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02880-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02880-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02880-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T06:18:08Z","timestamp":1785997088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02880-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2880"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02880-5","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Partial institutional endowments were received from Hirotsu Bio Science Inc. (Tokyo, Japan), Kinshu-kai Medical Corporation (Osaka, Japan), Kyowa-kai Medical Corporation (Kawanishi, Hyogo and Osaka, Japan), IDEA Consultants Inc. (Tokyo, Japan), Unitech Co., Ltd. (Chiba, Japan), and H.U. Group Research Institute G.K. (Tokyo, Japan). T.S. was employed by H.U. Group Research Institute G.K. until 2024. T.A. is currently employed by Unitech Co., Ltd. K.O. is currently employed by IDEA Consultants Inc. All other authors declare no conflicts of interest related to this work.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"327"}}